Angiotensin II Drives the Production of Tumor-Promoting Macrophages

Immunity

Volumn 38, Issue 2, 2013, Pages 296-308

  Cortez Retamozo, Virna ^a,b   Etzrodt, Martin ^a,b   Newton, Andita ^a   Ryan, Russell ^a   Pucci, Ferdinando ^a   Sio, Selena W ^a   Kuswanto, Wilson ^a   Rauch, Philipp J ^a   Chudnovskiy, Aleksey ^a   Iwamoto, Yoshiko ^a   Kohler, Rainer ^a   Marinelli, Brett ^a   Gorbatov, Rostic ^a   Wojtkiewicz, Gregory ^a   Panizzi, Peter ^a   Mino Kenudson, Mari ^a   Forghani, Reza ^a   Figueiredo, Jose Luiz ^a   Chen, John W ^a   Xavier, Ramnik ^a   Swirski, Filip K ^a   Nahrendorf, Matthias ^a   Weissleder, Ralph ^a,b   Pittet, Mikael J ^a   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGTR1A PROTEIN; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; GENE OVEREXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; LUNG NON SMALL CELL CANCER; MACROPHAGE; MACROPHAGE PRECURSOR; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

ADENOCARCINOMA; ANGIOTENSIN II; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL COMMUNICATION; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION; HEMATOPOIETIC STEM CELLS; HUMANS; LUNG NEOPLASMS; LYSOPHOSPHOLIPIDS; MACROPHAGES; MICE; MICE, TRANSGENIC; SIGNAL TRANSDUCTION; SPHINGOSINE; SPLEEN; TUMOR BURDEN;

EID: 84874227016     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2012.10.015     Document Type: Article

References (53)

1. AbdAlla S., Lother H., Langer A., el Faramawy Y., Quitterer U. Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis. Cell 2004, 119:343-354.
2. Bangalore S., Kumar S., Kjeldsen S.E., Makani H., Grossman E., Wetterslev J., Gupta A.K., Sever P.S., Gluud C., Messerli F.H. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Lancet Oncol. 2011, 12:65-82.
3. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 2010, 11:889-896.
4. Cortez-Retamozo V., Etzrodt M., Newton A., Rauch P.J., Chudnovskiy A., Berger C., Ryan R.J., Iwamoto Y., Marinelli B., Gorbatov R., et al. Origins of tumor-associated macrophages and neutrophils. Proc. Natl. Acad. Sci. USA 2012, 109:2491-2496.
5. De Palma M., Murdoch C., Venneri M.A., Naldini L., Lewis C.E. Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications. Trends Immunol. 2007, 28:519-524.
6. DeNardo D.G., Brennan D.J., Rexhepaj E., Ruffell B., Shiao S.L., Madden S.F., Gallagher W.M., Wadhwani N., Keil S.D., Junaid S.A., et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov 2011, 1:54-67.
7. DuPage M., Dooley A.L., Jacks T. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat. Protoc. 2009, 4:1064-1072.
8. Dutta P., Courties G., Wei Y., Leuschner F., Gorbatov R., Robbins C.S., Iwamoto Y., Thompson B., Carlson A.L., Heidt T., et al. Myocardial infarction accelerates atherosclerosis. Nature 2012, 487:325-329.
9. Fogg D.K., Sibon C., Miled C., Jung S., Aucouturier P., Littman D.R., Cumano A., Geissmann F. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 2006, 311:83-87.
10. Freedman M.H., Saunders E.F. Hematopoiesis in the human spleen. Am. J. Hematol. 1981, 11:271-275.
11. Gabrilovich D.I., Ostrand-Rosenberg S., Bronte V. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 2012, 12:253-268.
12. Geissmann F., Manz M.G., Jung S., Sieweke M.H., Merad M., Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661.
13. George A.J., Thomas W.G., Hannan R.D. The renin-angiotensin system and cancer: old dog, new tricks. Nat. Rev. Cancer 2010, 10:745-759.
14. Goodman J.W., Hodgson G.S. Evidence for stem cells in the peripheral blood of mice. Blood 1962, 19:702-714.
15. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140:883-899.
16. Hanahan D., Coussens L.M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012, 21:309-322.
17. Huang C.C., Chan W.L., Chen Y.C., Chen T.J., Lin S.J., Chen J.W., Leu H.B. Angiotensin II receptor blockers and risk of cancer in patients with systemic hypertension. Am. J. Cardiol. 2011, 107:1028-1033.
18. Jokubaitis V.J., Sinka L., Driessen R., Whitty G., Haylock D.N., Bertoncello I., Smith I., Péault B., Tavian M., Simmons P.J. Angiotensin-converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues. Blood 2008, 111:4055-4063.
19. Landsman L., Varol C., Jung S. Distinct differentiation potential of blood monocyte subsets in the lung. J. Immunol. 2007, 178:2000-2007.
20. Lang L. ACE inhibitors may reduce esophageal cancer incidence. Gastroenterology 2006, 131:343-344.
21. Lanz T.V., Ding Z., Ho P.P., Luo J., Agrawal A.N., Srinagesh H., Axtell R., Zhang H., Platten M., Wyss-Coray T., Steinman L. Angiotensin II sustains brain inflammation in mice via TGF-beta. J. Clin. Invest. 2010, 120:2782-2794.
22. Leuschner F., Panizzi P., Chico-Calero I., Lee W.W., Ueno T., Cortez-Retamozo V., Waterman P., Gorbatov R., Marinelli B., Iwamoto Y., et al. Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction. Circ. Res. 2010, 107:1364-1373.
23. Leuschner F., Rauch P.J., Ueno T., Gorbatov R., Marinelli B., Lee W.W., Dutta P., Wei Y., Robbins C., Iwamoto Y., et al. Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J. Exp. Med. 2012, 209:123-137.
24. Lever A.F., Hole D.J., Gillis C.R., McCallum I.R., McInnes G.T., MacKinnon P.L., Meredith P.A., Murray L.S., Reid J.L., Robertson J.W. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?. Lancet 1998, 352:179-184.
25. Lin C., Datta V., Okwan-Duodu D., Chen X., Fuchs S., Alsabeh R., Billet S., Bernstein K.E., Shen X.Z. Angiotensin-converting enzyme is required for normal myelopoiesis. FASEB J. 2011, 25:1145-1155.
26. Liu K., Waskow C., Liu X., Yao K., Hoh J., Nussenzweig M. Origin of dendritic cells in peripheral lymphoid organs of mice. Nat. Immunol. 2007, 8:578-583.
27. Ma F., Li Y., Jia L., Han Y., Cheng J., Li H., Qi Y., Du J. Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF β/Smad activation and cardiac fibrosis induced by angiotensin II. PLoS ONE 2012, 7:e35144.
28. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444.
29. Massberg S., Schaerli P., Knezevic-Maramica I., Köllnberger M., Tubo N., Moseman E.A., Huff I.V., Junt T., Wagers A.J., Mazo I.B., von Andrian U.H. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell 2007, 131:994-1008.
30. McAlpine H.M., Cobbe S.M. Neuroendocrine changes in acute myocardial infarction. Am. J. Med. 1988, 84(3A):61-66.
31. Movahedi K., Laoui D., Gysemans C., Baeten M., Stangé G., Van den Bossche J., Mack M., Pipeleers D., In't Veld P., De Baetselier P., Van Ginderachter J.A. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res. 2010, 70:5728-5739.
32. Nguyen D.X., Chiang A.C., Zhang X.H., Kim J.Y., Kris M.G., Ladanyi M., Gerald W.L., Massagué J. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 2009, 138:51-62.
33. Pittet M.J., Weissleder R. Intravital imaging. Cell 2011, 147:983-991.
34. Qian B.Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141:39-51.
35. Robbins C.S., Chudnovskiy A., Rauch P.J., Figueiredo J.L., Iwamoto Y., Gorbatov R., Etzrodt M., Weber G.F., Ueno T., van Rooijen N., et al. Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation 2012, 125:364-374.
36. Sawanobori Y., Ueha S., Kurachi M., Shimaoka T., Talmadge J.E., Abe J., Shono Y., Kitabatake M., Kakimi K., Mukaida N., Matsushima K. Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. Blood 2008, 111:5457-5466.
37. Schieffer B., Schieffer E., Hilfiker-Kleiner D., Hilfiker A., Kovanen P.T., Kaartinen M., Nussberger J., Harringer W., Drexler H. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation 2000, 101:1372-1378.
38. Schulz C., Gomez Perdiguero E., Chorro L., Szabo-Rogers H., Cagnard N., Kierdorf K., Prinz M., Wu B., Jacobsen S.E., Pollard J.W., et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012, 336:86-90.
39. Schwab S.R., Cyster J.G. Finding a way out: lymphocyte egress from lymphoid organs. Nat. Immunol. 2007, 8:1295-1301.
40. Shi C., Pamer E.G. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 2011, 11:762-774.
41. Sipahi I., Debanne S.M., Rowland D.Y., Simon D.I., Fang J.C. Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials. Lancet Oncol. 2010, 11:627-636.
42. Steidl C., Lee T., Shah S.P., Farinha P., Han G., Nayar T., Delaney A., Jones S.J., Iqbal J., Weisenburger D.D., et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N. Engl. J. Med. 2010, 362:875-885.
43. Swirski F.K., Nahrendorf M., Etzrodt M., Wildgruber M., Cortez-Retamozo V., Panizzi P., Figueiredo J.L., Kohler R.H., Chudnovskiy A., Waterman P., et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009, 325:612-616.
44. Taguchi A., Politi K., Pitteri S.J., Lockwood W.W., Faça V.M., Kelly-Spratt K., Wong C.H., Zhang Q., Chin A., Park K.S., et al. Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell 2011, 20:289-299.
45. Tsubakimoto Y., Yamada H., Yokoi H., Kishida S., Takata H., Kawahito H., Matsui A., Urao N., Nozawa Y., Hirai H., et al. Bone marrow angiotensin AT1 receptor regulates differentiation of monocyte lineage progenitors from hematopoietic stem cells. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1529-1536.
46. Ugel S., Peranzoni E., Desantis G., Chioda M., Walter S., Weinschenk T., Ochando J.C., Cabrelle A., Mandruzzato S., Bronte V. Immune Tolerance to Tumor Antigens Occurs in a Specialized Environment of the Spleen. Cell Rep. 2012, 2:628-639.
47. van Furth R., Cohn Z.A. The origin and kinetics of mononuclear phagocytes. J. Exp. Med. 1968, 128:415-435.
48. Weissleder R., Pittet M.J. Imaging in the era of molecular oncology. Nature 2008, 452:580-589.
49. Wilop S., von Hobe S., Crysandt M., Esser A., Osieka R., Jost E. Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy. J. Cancer Res. Clin. Oncol. 2009, 135:1429-1435.
50. Wright D.E., Wagers A.J., Gulati A.P., Johnson F.L., Weissman I.L. Physiological migration of hematopoietic stem and progenitor cells. Science 2001, 294:1933-1936.
51. Zhang B., Yao G., Zhang Y., Gao J., Yang B., Rao Z., Gao J. M2-polarized tumor-associated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma. Clinics (Sao Paulo) 2011, 66:1879-1886.
52. Zhang B.C., Gao J., Wang J., Rao Z.G., Wang B.C., Gao J.F. Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma. Med. Oncol. 2011, 28:1447-1452.
53. Zitvogel L., Apetoh L., Ghiringhelli F., Kroemer G. Immunological aspects of cancer chemotherapy. Nat. Rev. Immunol. 2008, 8:59-73.